Enter your email address:
Delivered by FeedBurner
« January 2012 |
| March 2012 »
The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.
Continue reading "European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year" »
Posted at 02:11 PM in Regulatory | Permalink
It is becoming increasingly clear that NICE and IQWiG have very different concerns on the reimbursement front, but it is only a matter of time before IQWiG gets its teeth into cost-benefit analyses.
Continue reading "European HTA Round-Up: NICE Focuses On Cost Effectiveness, IQWiG On Clinical Benefit, But Convergence May Come" »
Posted at 02:20 PM in Drug Development | Permalink